This is a routine annual meeting with no unexpected changes or financial implications. Shareholders should vote on the proposals, but there are no significant developments to act upon.
Price Chart
Executive Summary
Amphastar Pharmaceuticals is holding its 2026 annual meeting to elect three Class I directors, ratify the appointment of its independent auditor, and approve the compensation of its named executive officers. This is a routine annual shareholder meeting with no material financial impact.
Key Financial Metrics
Key Facts
- Annual meeting to elect three Class I directors: David Gaugh, William J. Peters, and Jacob Liawatidewi
- Ratification of Ernst & Young LLP as independent registered public accounting firm
- Advisory approval of named executive officer compensation
- Advisory approval of frequency of future executive compensation votes (1 year)
Financial Impact
No material financial impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001297184-26-000025 |
| Document: 0001297184-26-000025-index-headers.html | 0001297184-26-000025 |
| Document: 0001297184-26-000025-index.html | 0001297184-26-000025 |
| Document: 0001297184-26-000025.txt | 0001297184-26-000025 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | Insider Cluster | $26.27 | awaiting T+60 | — | $25.32 (−3.62%) |
Sep 21, 2026 4w ago | 144 | $24.32 | awaiting T+60 | — | $25.32 (+4.11%) |
Aug 21, 2026 9w ago | Institutional Cluster | $21.60 | awaiting T+60 | — | $25.32 (+17.22%) |
Aug 12, 2026 10w ago | Insider Cluster | $20.18 | awaiting T+60 | — | $25.32 (+25.47%) |
Aug 11, 2026 10w ago | 144 | $20.31 | awaiting T+60 | — | $25.32 (+24.67%) |
Jul 13, 2026 15w ago | 8-K | $19.29 $25.91 | ▲ +34.32% | ▲ +30.32% | $25.32 (+31.26%) |
Jul 7, 2026 15w ago | 8-K | $18.88 $25.35 | ▼ −34.27% | ▼ −31.78% | $25.32 (−34.11%) |
Apr 13, 2026 27w ago | DEFA14A | $21.38 $19.02 | ▼ −11.04% | ▼ −19.56% | $25.32 (+18.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers